Mechanical and biologic link between cartilage and subchondral bone in osteoarthritis

Arthritis Care and Research

Volumn 64, Issue 7, 2012, Pages 960-967

  Zhang, Li Zhi ^a   Zheng, Hong Ai ^b   Jiang, Yao ^a   Tu, Yi Hui ^a   Jiang, Pei Hong ^a   Yang, An Li ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF ELECTRIC POWER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR;

ARTICULAR CARTILAGE; BIOLOGICAL ACTIVITY; BIOMECHANICS; BONE; BONE ATROPHY; CARTILAGE; CARTILAGE CELL; DISEASE COURSE; EPIGENETICS; GENE EXPRESSION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

BIOMECHANICS; BONE AND BONES; CARTILAGE; CELL COMMUNICATION; DISEASE PROGRESSION; HUMANS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 84863451354     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21640     Document Type: Review

References (97)

1. Zhang Y, Niu J, Felson DT, Choi HK, Nevitt M, Neogi T. Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res (Hoboken) 2010; 62:1527-32.
2. Toivanen AT, Heliovaara M, Impivaara O, Arokoski JP, Knekt P, Lauren H, et al. Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis: a population-based study with a follow-up of 22 years. Rheumatology (Oxford) 2010;49:308-14.
3. Muthuri SG, Hui M, Doherty M, Zhang W. What if we prevent obesity? Risk reduction in knee osteoarthritis estimated through a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2011;63:982-90.
4. Loughlin J. Osteoarthritis year 2010 in review: genetics. Osteoarthritis Cartilage 2011;19:342-5.
5. Williams FM. Biomarkers: in combination they may do better. Arthritis Res Ther 2009;11:130.
6. Anderson-MacKenzie JM, Quasnichka HL, Starr RL, Lewis EJ, Billingham ME, Bailey AJ. Fundamental subchondral bone changes in spontaneous knee osteoarthritis. Int J Biochem Cell Biol 2005;37:224-36. (Pubitemid 39286038)
7. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Monoiodoacetate- induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003;31:619-24. (Pubitemid 37433471)
8. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005;13:632-41. (Pubitemid 40867863)
9. Blair-Levy JM, Watts CE, Fiorentino NM, Dimitriadis EK, Marini JC, Lipsky PE. A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse model. Arthritis Rheum 2008;58:1096-106. (Pubitemid 351564012)
10. Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009;60:3723-33.
11. Madry H, van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc 2010;18:419-33.
12. Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 2010;24:51-70.
13. Imhof H, Sulzbacher I, Grampp S, Czerny C, Youssefzadeh S, Kainberger F. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol 2000;35:581-8.
14. Frobell RB, Nevitt MC, Hudelmaier M, Wirth W, Wyman BT, Benichou O, et al, for the Osteoarthritis Initiative Investigators. Femorotibial subchondral bone area and regional cartilage thickness: a cross-sectional description in healthy reference cases and various radiographic stages of osteoarthritis in 1,003 knees from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2010;62:1612-23.
15. Neogi T, Nevitt M, Niu J, Sharma L, Roemer F, Guermazi A, et al. Subchondral bone attrition may be a reflection of compartment-specific mechanical load: the MOST Study. Ann Rheum Dis 2010;69:841-4.
16. Janusz MJ, Hookfin EB, Heitmeyer SA, Woessner JF, Freemont AJ, Hoyland JA, et al. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage 2001;9:751-60. (Pubitemid 33076767)
17. Botter SM, van Osch GJ, Waarsing JH, van der Linden JC, Verhaar JA, Pols HA, et al. Cartilage damage pattern in relation to subchondral plate thickness in a collagenase-induced model of osteoarthritis. Osteoarthritis Cartilage 2008;16:506-14. (Pubitemid 351426268)
18. Carlson CS, Loeser RF, Purser CB, Gardin JF, Jerome CP. Osteoarthritis in cynomolgus macaques. III. Effects of age, gender, and subchondral bone thickness on the severity of disease. J Bone Miner Res 1996;11:1209-17. (Pubitemid 26282520)
19. Rogers J, Shepstone L, Dieppe P. Is osteoarthritis a systemic disorder of bone? Arthritis Rheum 2004;50:452-7. (Pubitemid 38198829)
20. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 2010;1192:230-7.
21. Bellido M, Lugo L, Roman-Blas JA, Castaneda S, Caeiro JR, Dapia S, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010;12:R152.
22. Pan J, Zhou X, Li W, Novotny JE, Doty SB, Wang L. In situ measurement of transport between subchondral bone and articular cartilage. J Orthop Res 2009;27:1347-52.
23. Lyons TJ, McClure SF, Stoddart RW, McClure J. The normal human chondro-osseous junctional region: evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet Disord 2006;7:52.
24. Amin AK, Huntley JS, Simpson AH, Hall AC. Chondrocyte survival in articular cartilage: the influence of subchondral bone in a bovine model. J Bone Joint Surg Br 2009;91:691-9.
25. Arkill KP, Winlove CP. Solute transport in the deep and calcified zones of articular cartilage. Osteoarthritis Cartilage 2008;16:708-14. (Pubitemid 351753712)
26. Jiao K, Niu LN, Wang MQ, Dai J, Yu SB, Liu XD, et al. Subchondral bone loss following orthodontically induced cartilage degradation in the mandibular condyles of rats. Bone 2011;48:362-71.
27. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY, Henrotin YE. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2005;13:988-97. (Pubitemid 41536131)
28. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY, Henrotin YE. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes: this effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005;13:979-87. (Pubitemid 41536130)
29. Lin YY, Tanaka N, Ohkuma S, Iwabuchi Y, Tanne Y, Kamiya T, et al. Applying an excessive mechanical stress alters the effect of subchondral osteoblasts on chondrocytes in a coculture system. Eur J Oral Sci 2010;118:151-8.
30. Brandt KD. Neuromuscular aspects of osteoarthritis: a perspective. Novartis Found Symp 2004;260:49-58; discussion 58-63; 100-4; 277-109.
31. Zhu F, Wang P, Lee NH, Goldring MB, Konstantopoulos K. Prolonged application of high fluid shear to chondrocytes recapitulates gene expression profiles associated with osteoarthritis. PLoS One 2011;5:e15174.
32. Cox LG, van Rietbergen B, van Donkelaar CC, Ito K. Analysis of bone architecture sensitivity for changes in mechanical loading, cellular activity, mechanotransduction, and tissue properties. Biomech Model Mechanobiol 2011;10:701-12.
33. Natoli RM, Scott CC, Athanasiou KA. Temporal effects of impact on articular cartilage cell death, gene expression, matrix biochemistry, and biomechanics. Ann Biomed Eng 2008; 36:780-92.
34. Kreke MR, Sharp LA, Lee YW, Goldstein AS. Effect of intermittent shear stress on mechanotransductive signaling and osteoblastic differentiation of bone marrow stromal cells. Tissue Eng Part A 2008;14:529-37. (Pubitemid 351520460)
35. MacLean JJ, Roughley PJ, Monsey RD, Alini M, Iatridis JC. In vivo intervertebral disc remodeling: kinetics of mRNA expression in response to a single loading event. J Orthop Res 2008;26:579-88.
36. Howard MR, Millward-Sadler SJ, Vasilliou AS, Salter DM, Quinn JP. Mechanical stimulation induces preprotachykinin gene expression in osteoarthritic chondrocytes which is correlated with modulation of the transcription factor neuron restrictive silence factor. Neuropeptides 2008;42:681-6.
37. Kim SY, Im GI. The expressions of the SOX trio, PTHrP (parathyroid hormone-related peptide)/IHH (Indian hedgehog protein) in surgically induced osteoarthritis of the rat. Cell Biol Int 2011;35:529-35.
38. Millward-Sadler SJ, Wright MO, Davies LW, Nuki G, Salter DM. Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum 2000;43:2091-9.
39. Takada K, Hirose J, Senba K, Yamabe S, Oike Y, Gotoh T, et al. Enhanced apoptotic and reduced protective response in chondrocytes following endoplasmic reticulum stress in osteoarthritic cartilage. Int J Exp Pathol 2011;92:232-42.
40. Holledge MM, Millward-Sadler SJ, Nuki G, Salter DM. Mechanical regulation of proteoglycan synthesis in normal and osteoarthritic human articular chondrocytes: roles for α5 and αVβ5 integrins. Biorheology 2008;45:275-88.
41. Chai DH, Arner EC, Griggs DW, Grodzinsky AJ. Av and β1 integrins regulate dynamic compression-induced proteoglycan synthesis in 3D gel culture by distinct complementary pathways. Osteoarthritis Cartilage 2010;18:249-56.
42. Blain EJ. Involvement of the cytoskeletal elements in articular cartilage homeostasis and pathology. Int J Exp Pathol 2009; 90:1-15.
43. Salter DM, Millward-Sadler SJ, Nuki G, Wright MO. Differential responses of chondrocytes from normal and osteoarthritic human articular cartilage to mechanical stimulation. Biorheology 2002;39:97-108. (Pubitemid 34626053)
44. Sanchez C, Gabay O, Salvat C, Henrotin YE, Berenbaum F. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. Osteoarthritis Cartilage 2009;17:473-81.
45. Schroeppel JP, Crist JD, Anderson HC, Wang J. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol 2011;26:377-94.
46. Okada A, Okada Y. Progress of research in osteoarthritis: metalloproteinases in osteoarthritis. Clin Calcium 2009;19: 1593-601.
47. Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging 2010;27:95-115.
48. Leipzig ND, Eleswarapu SV, Athanasiou KA. The effects of TGF-β1 and IGF-I on the biomechanics and cytoskeleton of single chondrocytes. Osteoarthritis Cartilage 2006;14:1227-36. (Pubitemid 44774439)
49. Sakao K, Takahashi KA, Mazda O, Arai Y, Tonomura H, Inoue A, et al. Enhanced expression of interleukin-6, matrix metalloproteinase- 13, and receptor activator of NF-κB ligand in cells derived from osteoarthritic subchondral bone. J Orthop Sci 2008;13:202-10. (Pubitemid 351799216)
50. Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, et al. Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002;10:491-500. (Pubitemid 34679302)
51. Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 2006;38:333-41. (Pubitemid 43255427)
52. Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008;26:295-304. (Pubitemid 351659137)
53. Tat SK, Pelletier JP, Velasco CR, Padrines M, Martel-Pelletier J. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J Med 2009;58: 29-40.
54. Boschetti F, Peretti GM. Tensile and compressive properties of healthy and osteoarthritic human articular cartilage. Biorheology 2008;45:337-44.
55. Nakaoka R, Hsiong SX, Mooney DJ. Regulation of chondrocyte differentiation level via co-culture with osteoblasts. Tissue Eng 2006;12:2425-33. (Pubitemid 46141266)
56. Sniekers YH, Weinans H, van Osch GJ, van Leeuwen JP. Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis. Arthritis Res Ther 2010;12:R182.
57. Roman-Blas JA, Castaneda S, Largo R, Herrero-Beaumont G. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther 2009;11:241.
58. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010;26:355-69.
59. Sakakura Y, Tsuruga E, Irie K, Hosokawa Y, Nakamura H, Yajima T. Immunolocalization of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice. J Anat 2005;207:325-37. (Pubitemid 41479537)
60. Usui M, Xing L, Drissi H, Zuscik M, O'Keefe R, Chen D, et al. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J Bone Miner Res 2008;23:314-25. (Pubitemid 351304662)
61. Upton AR, Holding CA, Dharmapatni AA, Haynes DR. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. Rheumatol Int 2012;32:535-40.
62. Hopwood B, Tsykin A, Findlay DM, Fazzalari NL. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling. Arthritis Res Ther 2007;9:R100.
63. Sakao K, Takahashi KA, Arai Y, Saito M, Honjyo K, Hiraoka N, et al. Asporin and transforming growth factor-β gene expression in osteoblasts from subchondral bone and osteophytes in osteoarthritis. J Orthop Sci 2009;14:738-47.
64. Van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB. TGF-β signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 2009;17:1539-45.
65. Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum 2010;62:1393-402.
66. Blom AB, van Lent PL, van der Kraan PM, van den Berg WB. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. Curr Drug Targets 2010;11:620-9.
67. Blom AB, Brockbank SM, van Lent PL, van Beuningen HM, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009;60:501-12.
68. Papathanasiou I, Malizos KN, Tsezou A. Low-density lipoprotein receptor-related protein 5 (LRP5) expression in human osteoarthritic chondrocytes. J Orthop Res 2010;28:348-53.
69. Kumarasinghe DD, Perilli E, Tsangari H, Truong L, Kuliwaba JS, Hopwood B, et al. Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis Cartilage 2010;18:1337-44.
70. Prasadam I, van Gennip S, Friis T, Shi W, Crawford R, Xiao Y. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum 2010;62: 1349-60.
71. Prasadam I, Friis T, Shi W, van Gennip S, Crawford R, Xiao Y. Osteoarthritic cartilage chondrocytes alter subchondral bone osteoblast differentiation via MAPK signalling pathway involving ERK1/2. Bone 2010;46:226-35.
72. Alcaraz MJ, Megias J, Garcia-Arnandis I, Clerigues V, Guillen MI. New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol 2010;80:13-21.
73. Valdes AM, Doherty M, Spector TD. The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann Rheum Dis 2008;67:124-7.
74. Valdes AM, Loughlin J, Timms KM, van Meurs JJ, Southam L, Wilson SG, et al. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet 2008;82:1231-40.
75. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010;69:1502-10.
76. Mateescu RG, Burton-Wurster NI, Tsai K, Phavaphutanon J, Zhang Z, Murphy KE, et al. Identification of quantitative trait loci for osteoarthritis of hip joints in dogs. Am J Vet Res 2008;69:1294-300.
77. Da Silva MA, Yamada N, Clarke NM, Roach HI. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res 2009;27:593-601.
78. Cheung KS, Hashimoto K, Yamada N, Roach HI. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA demethylation. Rheumatol Int 2009;29:525-34.
79. Imagawa K, de Andres MC, Hashimoto K, Pitt D, Itoi E, Goldring MB, et al. The epigenetic effect of glucosamine and a nuclear factor-κB (NF-κB) inhibitor on primary human chondrocytes: implications for osteoarthritis. Biochem Biophys Res Commun 2011;405:362-7.
80. Sanchez C, Deberg MA, Bellahcene A, Castronovo V, Msika P, Delcour JP, et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008;58:442-55. (Pubitemid 351294879)
81. Rosenthal AK, Gohr CM, Ninomiya J, Wakim BT. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011;63:401-11.
82. Valdes AM, Spector TD. The contribution of genes to osteoarthritis. Med Clin North Am 2009;93:45-66.
83. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007;66:1616-21. (Pubitemid 350205450)
84. Roach HI, Aigner T. DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage 2007;15:128-37. (Pubitemid 46132098)
85. Schmitz N, Kraus VB, Aigner T. Targets to tackle: the pathophysiology of the disease. Curr Drug Targets 2010;11:521-7.
86. Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, et al. Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers. Arthritis Res Ther 2009;11:R115.
87. Menetrey J, Unno-Veith F, Madry H, Van Breuseghem I. Epidemiology and imaging of the subchondral bone in articular cartilage repair. Knee Surg Sports Traumatol Arthrosc 2010; 18:463-71.
88. Graichen H, Al-Shamari D, Hinterwimmer S, von Eisenhart- Rothe R, Vogl T, Eckstein F. Accuracy of quantitative magnetic resonance imaging in the detection of ex vivo focal cartilage defects. Ann Rheum Dis 2005;64:1120-5. (Pubitemid 41113343)
89. Hunter DJ, Niu J, Zhang Y, Totterman S, Tamez J, Dabrowski C, et al. Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative. Ann Rheum Dis 2009;68:349-56.
90. Berry PA, Maciewicz RA, Wluka AE, Downey-Jones MD, Forbes A, Hellawell CJ, et al. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure. Ann Rheum Dis 2010;69:1816-22.
91. Pakin SK, Cavalcanti C, La Rocca R, Schweitzer ME, Regatte RR. Ultra-high-field MRI of knee joint at 7.0T: preliminary experience. Acad Radiol 2006;13:1135-42. (Pubitemid 44279452)
92. Herrero-Beaumont G, Roman-Blas JA, Castaneda S, Jimenez SA. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum 2009;39:71-80.
93. Gudas R, Simonaityte R, Cekanauskas E, Tamosiunas R. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children. J Pediatr Orthop 2009;29:741-8.
94. Chambers HG. Osteochondral autologous transplantation was more effective than microfracture for osteochondritis dissecans in children younger than eighteen years. J Bone Joint Surg Am 2010;92:1998.
95. Smolders JM, Kock NB, Koeter S, van Susante JL. Osteochondral autograft transplantation for osteochondritis dissecans of the knee: preliminary results of a prospective case series. Acta Orthop Belg 2010;76:208-18.
96. Martel-Pelletier J, Pelletier JP. Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahis 2010;21:2-14.
97. Englund M. The role of biomechanics in the initiation and progression of OA of the knee. Best Pract Res Clin Rheumatol 2010;24:39-46.